The shift to more connected health isn't showing signs of slowing down, and medtech continues to play a significant role.

Using the assistance of Homeland Security Investigations and a United States Border Patrol drug detection K-9, detectives ...

Class II classifications are enforced in "a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the ...

The FDA's Center for Drug Evaluation and Research on Wednesday officially launched a new center of excellence to better ...

The removal of Zepbound and Mounjaro from the regulator’s shortage list could lead to restrictions on pharmacies making ...

Hims & Hers Health shares tumbled Thursday after the Food and Drug Administration said Eli Lilly's popular weight-loss drugs ...

The FDA says the shortage of tirzepatide injection — a glucagon-like peptide 1 medication used for diabetes and weight loss — ...

In vitro and in vivo studies can supplement clinical trials to help better understand the drug candidate's behavior and, at ...

The shortage of Eli Lilly’s (LLY) blockbuster diabetes and weight loss drugs is officially over, according to the U.S. Food ...

Arrowhead's plozasiran shows promising Phase 3 data for FCS, with potential blockbuster status, but faces competition. Learn ...

Indianapolis-based Eli Lilly’s supply of Mounjaro, which is used to treat Type 2 diabetes, and popular weight-loss drug ...

Aldeyra Therapeutics has resubmitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for topical ...